Abstract:Background: Use of organophosphate flame retardants (OPFRs) including tris(1,3-dichloro-2-propyl) phosphate, triphenyl phosphate, tris(1-chloro-2-propyl) phosphate, and tris-2-chloroethyl phosphate, in consumer products is on the rise because of the recent phase out of polybrominated diphenyl ether (PBDE) flame retardants. Some of these chemicals are also used as plasticizers or lubricants in many consumer products. Objectives: To assess human exposure to these chlorinated and non-chlorinated organophosphates, and non-PBDE brominated chemicals in a representative sample of the U.S. general population 6years and older from the 2013-2014 National Health and Nutrition Examination Survey (NHANES). Methods: We used solid-phase extraction coupled to isotope dilution high-performance liquid chromatography-tandem mass spectrometry after enzymatic hydrolysis of conjugates to analyze 2666 NHANES urine samples for nine biomarkers: diphenyl phosphate (DPHP), bis(1,3-dichloro-2-propyl) phosphate (BDCIPP), bis-(1-chloro-2-propyl) phosphate (BCIPP), bis-2-chloroethyl phosphate (BCEP), di-n-butyl phosphate (DNBP), di-p-cresylphosphate (DpCP), di-o-cresylphosphate (DoCP), dibenzyl phosphate (DBzP), and 2,3,4,5-tetrabromobenzoic acid (TBBA). We calculated the geometric mean (GM) and distribution percentiles for the urinary concentrations (both in micrograms per liter [μg/L] and in micrograms per gram of creatinine). We only calculated GMs for analytes with an overall weighted frequency of detection >60%. For those analytes, we also a) determined weighted Pearson correlations among the log10-transformed concentrations, and b) used regression models to evaluate associations of various demographic parameters with urinary concentrations of these biomarkers. Results: We detected BDCIPP and DPHP in approximately 92% of study participants, BCEP in 89%, DNBP in 81%, and BCIPP in 61%. By contrast, we detected the other biomarkers much less frequently: DpCP (13%), DoCP (0.1%), TBBA (5%), and did not detect DBzP in any of the participants. Concentration ranges were highest for DPHP (<0.16-193μg/L), BDCIPP (<0.11-169μg/L), and BCEP (<0.08-110μg/L). Regardless of race/ethnicity, 6-11year old children had significantly higher BCEP adjusted GMs than other age groups. Females had significantly higher DPHP and BDCIPP adjusted GM than males, and were more likely than males to have DPHP concentrations above the 95th percentile (odds ratio=3.61; 95% confidence interval, 2.01-6.48). Conclusions: Our results confirm findings from previous studies suggesting human exposure to OPFRs, and demonstrate, for the first time, widespread exposure to several OPFRs among a representative sample of the U.S. general population 6years of age and older. The observed differences in concentrations of certain OPFRs biomarkers by race/ethnicity, in children compared to other age groups, and in females compared to males may reflect differences in lifestyle and exposure patterns. These NHANES data can be used to stablish a nationally representative baseline of exposures to OPFRs and when combined with future 2-year survey data, to evaluate exposure trends.

A Pilot Study of Metabolites of Organophosphorus Flame Retardants in Paired Maternal Urine and Amniotic Fluid Samples: Potential Exposure Risks of Tributyl Phosphate to Pregnant Women

Exposure levels and maternal transfer of emerging organophosphate flame retardants (OPFRs) in pregnant women: Comparison with traditional OPFRs

Organophosphate esters in a cohort of pregnant women: Variability and predictors of exposure

Urinary Metabolites of Organophosphate Flame Retardants in 0-5-year-old Children: Potential Exposure Risk for Inpatients and Home-Stay Infants.

Prenatal Exposure to Emerging and Traditional Organophosphate Flame Retardants: Regional Comparison, Transplacental Transfer, and Birth Outcomes.

Levels of Urinary Metabolites of Organophosphate Flame Retardants, TDCIPP, and TPHP, in Pregnant Women in Shanghai

Descriptive analysis of organophosphate ester metabolites in a pan-Canadian pregnancy cohort

Organophosphate ester and phthalate ester metabolites in urine from primiparas in Shenzhen, China: Implications for health risks

Organophosphorus Flame Retardants in Pregnant Women and Their Transfer to Chorionic Villi

Urinary Metabolites of Organophosphate Esters and Implications for Exposure Pathways in Adolescents from Eastern China.

Urinary Metabolites of Organophosphate Flame Retardants in China: Health Risk from Tris(2-Chloroethyl) Phosphate (TCEP) Exposure.

Effect of E-waste Recycling on Urinary Metabolites of Organophosphate Flame Retardants and Plasticizers and Their Association with Oxidative Stress

Organophosphorus Flame Retardants and Their Metabolites in Paired Human Blood and Urine

Associations between the exposure to organophosphate flame retardants during early pregnancy and the risk of spontaneous abortion based on metabolomics combined with tandem mass spectrometry

Exposure to organophosphate flame esters during early pregnancy and risk of spontaneous abortion: A case-control study

Prenatal exposure to organophosphate esters and behavioral development in young children in the Pregnancy, Infection, and Nutrition Study

Urinary Metabolites of Organophosphate Esters: Concentrations and Age Trends in Australian Children.

Concentrations of organophosphate flame retardants and plasticizers in urine from young children in Queensland, Australia and associations with environmental and behavioural factors

Maternal exposure to organophosphate flame retardants and neonatal anthropometric measures

Exposure to Organophosphate Ester Flame Retardants and Plasticizers During Pregnancy: Thyroid Endocrine Disruption and Mediation Role of Oxidative Stress.

Exposure to organophosphate flame retardant chemicals in the U.S. general population: Data from the 2013-2014 National Health and Nutrition Examination Survey